162 related articles for article (PubMed ID: 35246583)
1. Elevated lipoprotein(a) and genetic polymorphisms in the LPA gene may predict cardiovascular events.
Gu JX; Huang J; Li SS; Zhou LH; Yang M; Li Y; Zhang AM; Yin Y; Zhang N; Jia M; Su M
Sci Rep; 2022 Mar; 12(1):3588. PubMed ID: 35246583
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention.
Li ZG; Li G; Zhou YL; Chen ZJ; Yang JQ; Zhang Y; Sun S; Zhong SL
Lipids Health Dis; 2013 Aug; 12():127. PubMed ID: 23978127
[TBL] [Abstract][Full Text] [Related]
3. Correlations between lipoprotein(a) gene polymorphisms and calcific aortic valve disease and coronary heart disease in Han Chinese.
Dong H; Cong H; Wang J; Jiang Y; Liu C; Zhang Y; Zhu Y; Wang Q
J Int Med Res; 2020 Oct; 48(10):300060520965353. PubMed ID: 33100089
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels.
Emdin CA; Khera AV; Natarajan P; Klarin D; Won HH; Peloso GM; Stitziel NO; Nomura A; Zekavat SM; Bick AG; Gupta N; Asselta R; Duga S; Merlini PA; Correa A; Kessler T; Wilson JG; Bown MJ; Hall AS; Braund PS; Samani NJ; Schunkert H; Marrugat J; Elosua R; McPherson R; Farrall M; Watkins H; Willer C; Abecasis GR; Felix JF; Vasan RS; Lander E; Rader DJ; Danesh J; Ardissino D; Gabriel S; Saleheen D; Kathiresan S; ;
J Am Coll Cardiol; 2016 Dec; 68(25):2761-2772. PubMed ID: 28007139
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
Clarke R; Peden JF; Hopewell JC; Kyriakou T; Goel A; Heath SC; Parish S; Barlera S; Franzosi MG; Rust S; Bennett D; Silveira A; Malarstig A; Green FR; Lathrop M; Gigante B; Leander K; de Faire U; Seedorf U; Hamsten A; Collins R; Watkins H; Farrall M;
N Engl J Med; 2009 Dec; 361(26):2518-28. PubMed ID: 20032323
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes.
Qi Q; Workalemahu T; Zhang C; Hu FB; Qi L
Eur Heart J; 2012 Feb; 33(3):325-34. PubMed ID: 21900290
[TBL] [Abstract][Full Text] [Related]
7. Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemia.
Page MM; Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
Clin Chim Acta; 2020 Nov; 510():211-215. PubMed ID: 32681934
[TBL] [Abstract][Full Text] [Related]
8. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.
Zewinger S; Kleber ME; Tragante V; McCubrey RO; Schmidt AF; Direk K; Laufs U; Werner C; Koenig W; Rothenbacher D; Mons U; Breitling LP; Brenner H; Jennings RT; Petrakis I; Triem S; Klug M; Filips A; Blankenberg S; Waldeyer C; Sinning C; Schnabel RB; Lackner KJ; Vlachopoulou E; Nygård O; Svingen GFT; Pedersen ER; Tell GS; Sinisalo J; Nieminen MS; Laaksonen R; Trompet S; Smit RAJ; Sattar N; Jukema JW; Groesdonk HV; Delgado G; Stojakovic T; Pilbrow AP; Cameron VA; Richards AM; Doughty RN; Gong Y; Cooper-DeHoff R; Johnson J; Scholz M; Beutner F; Thiery J; Smith JG; Vilmundarson RO; McPherson R; Stewart AFR; Cresci S; Lenzini PA; Spertus JA; Olivieri O; Girelli D; Martinelli NI; Leiherer A; Saely CH; Drexel H; Mündlein A; Braund PS; Nelson CP; Samani NJ; Kofink D; Hoefer IE; Pasterkamp G; Quyyumi AA; Ko YA; Hartiala JA; Allayee H; Tang WHW; Hazen SL; Eriksson N; Held C; Hagström E; Wallentin L; Åkerblom A; Siegbahn A; Karp I; Labos C; Pilote L; Engert JC; Brophy JM; Thanassoulis G; Bogaty P; Szczeklik W; Kaczor M; Sanak M; Virani SS; Ballantyne CM; Lee VV; Boerwinkle E; Holmes MV; Horne BD; Hingorani A; Asselbergs FW; Patel RS; ; Krämer BK; Scharnagl H; Fliser D; März W; Speer T
Lancet Diabetes Endocrinol; 2017 Jul; 5(7):534-543. PubMed ID: 28566218
[TBL] [Abstract][Full Text] [Related]
9. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH
BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223
[TBL] [Abstract][Full Text] [Related]
10. Investigation of LPA sequence variants rs6415084, rs3798220 with conventional coronary artery disease in Iranian CAD patients.
Rouhani B; Ghaderian SMH; Salehi Z
Hum Antibodies; 2019; 27(2):99-104. PubMed ID: 30594920
[TBL] [Abstract][Full Text] [Related]
11. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction.
Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
J Am Coll Cardiol; 2013 Mar; 61(11):1146-56. PubMed ID: 23375930
[TBL] [Abstract][Full Text] [Related]
12. LPA Gene, Ethnicity, and Cardiovascular Events.
Lee SR; Prasad A; Choi YS; Xing C; Clopton P; Witztum JL; Tsimikas S
Circulation; 2017 Jan; 135(3):251-263. PubMed ID: 27831500
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study.
Hopewell JC; Clarke R; Parish S; Armitage J; Lathrop M; Hager J; Collins R;
Circ Cardiovasc Genet; 2011 Feb; 4(1):68-73. PubMed ID: 21252144
[TBL] [Abstract][Full Text] [Related]
14. Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic
Guertin J; Kaiser Y; Manikpurage H; Perrot N; Bourgeois R; Couture C; Wareham NJ; Bossé Y; Pibarot P; Stroes ESG; Mathieu P; Clavel MA; Thériault S; Boekholdt SM; Arsenault BJ
Circ Genom Precis Med; 2021 Aug; 14(4):e003271. PubMed ID: 34279996
[TBL] [Abstract][Full Text] [Related]
15. The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A.
Grüneis R; Lamina C; Di Maio S; Schönherr S; Zoescher P; Forer L; Streiter G; Peters A; Gieger C; Köttgen A; Kronenberg F; Coassin S
Atherosclerosis; 2022 May; 349():151-159. PubMed ID: 35534298
[TBL] [Abstract][Full Text] [Related]
16. Relationship between LPA SNPs and inflammatory burden in patients with preeclampsia to address future cardiovascular risk.
Tuten A; Gungor Z; Ekmekci H; Ekmekci OB; Kucur M; Yilmaz N; Donma O; Sonmez H; Acıkgoz A; Madazlı R
J Matern Fetal Neonatal Med; 2021 Mar; 34(6):898-906. PubMed ID: 31113255
[TBL] [Abstract][Full Text] [Related]
17. Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes: A Mendelian Randomization Analysis.
Lamina C; Kronenberg F;
JAMA Cardiol; 2019 Jun; 4(6):575-579. PubMed ID: 31017618
[TBL] [Abstract][Full Text] [Related]
18. KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly.
Akao H; Polisecki E; Kajinami K; Trompet S; Robertson M; Ford I; Jukema JW; de Craen AJ; Westendorp RG; Shepherd J; Packard C; Buckley BM; Schaefer EJ
Atherosclerosis; 2012 Feb; 220(2):456-62. PubMed ID: 22192511
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk.
Coassin S; Chemello K; Khantalin I; Forer L; Döttelmayer P; Schönherr S; Grüneis R; Chong-Hong-Fong C; Nativel B; Ramin-Mangata S; Gallo A; Roche M; Muelegger B; Gieger C; Peters A; Zschocke J; Marimoutou C; Meilhac O; Lamina C; Kronenberg F; Blanchard V; Lambert G
Circ Genom Precis Med; 2022 Apr; 15(2):e003489. PubMed ID: 35133173
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.
Emanuele E; Peros E; Minoretti P; D'Angelo A; Piccinni MN; Montagna L; Geroldi D
Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):193-9. PubMed ID: 15553596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
